@Superdude - Additional questions to ask:

1) Vaccine was based on efficacy trials but not safety trials. - why?

2) Why are we not testing T-cell immunity (IgG status) prior to requiring revaccination in those recently or previously infected? We use IgG with Varicella, MMR, and Hep B immunity testing. Why not COVID?

3) For those that have had COVID-19, what risk does the vaccine post to them? - as post release data appears to be showing these people are at higher risk of adverse events.

4) What populations will have severe reaction to this vaccine?